Vasculitis and myelodysplasia

Israel Medical Association Journal

Volumn 10, Issue 2, 2008, Pages 156-157

  Belizna, Christina C ^a,b   Kerleau, Jean Marc ^a   Heron, Francois ^a   Cailleux, Nicole ^a   Lévesque, Hervé ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Hematology; Leukemia; Myelodysplasia; Refractory anemia; Vasculitis

Indexed keywords

ALPHA 2 GLOBULIN; CORTICOSTEROID; HEMOGLOBIN;

AGED; ARTICLE; CASE REPORT; DRUG MEGADOSE; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; KARYOTYPE; LUNG BIOPSY; MALE; MEGALOCYTOSIS; MYELODYSPLASIA; PANCYTOPENIA; PLEURA DISEASE; PNEUMONIA; REFRACTORY ANEMIA WITH EXCESS BLASTS; SKIN INFLAMMATION; SYSTEMIC VASCULITIS; THORAX RADIOGRAPHY; BIOPSY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; LEUKOCYTE COUNT; MYELODYSPLASTIC SYNDROME; VASCULITIS;

AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; MALE; MYELODYSPLASTIC SYNDROMES; VASCULITIS;

EID: 42949102502     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Liozon E, Loustaud V, Fauchais AL, et al. Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literature. J Rheumatol 2006;33:1606-14.
2. Brickner LA, Scannell KA. Medium-vessel PAN-type-vasculitis associated with myelodysplastic syndrome and presenting as bilateral perinephric hematomas. Clin Exp Rheumatol 1997;15:221-2.
3. Giannouli S, Tzoanopoulos D, Ritis K, Kartalis G, Moutsopoulos HM, Voulgarelis M. Autoimmune manifestations in human myelodysplasia: a positive correlation with (IRF-I) expression. Ann Rheum Dis 2004;63:578-82.
4. Billstrom R, Johansson H, Johansson B, Mitelman F. Immune-mediated complications in patients with myelodysplastic syndromes-clinical and cytogenetic features. Eur J Haematol 1995;55:42-8.
5. Sailler L, Joseph-Hein K, Astudillo L, et al. Pustular vasculitis in a patient with T-cell large granular lymphocyte proliferation and myelodysplasia. Successful treatment by cyclosporin. Br J Dermatol 2003;149:893-4.